A study of the microbiology of diabetic foot infections in a teaching hospital in Kuwait
Affiliations
Affiliations
- Department of Microbiology, Al-Amiri Hospital, Kuwait. drbanwan@gmail.com
Abstract
The purpose of this study was to determine the microbiological profile of diabetic foot infections (DFIs) and assess the antibiotic susceptibility of the causative agents. Data were obtained from a retrospective analysis of DFI samples collected from June 2007 to July 2008. Specimens were cultured using optimal aerobic and anaerobic microbiological techniques, and antibiotic susceptibility testing was performed according to the methods recommended by the Clinical and Laboratory Standards Institute (CLSI). Extended-spectrum β-lactamase (ESBL) production was measured using the double disk synergy test and the ESBL Etest. A total of 440 patients were diagnosed with DFIs during this period, and a total of 777 pathogens were isolated from these patients with an average of 1.8 pathogens per lesion. We isolated more Gram-negative pathogens (51.2%) than Gram-positive pathogens (32.3%) or anaerobes (15.3%). Polymicrobial infection was identified in 75% of the patients. The predominant organisms isolated were members of the Enterobacteriaceae family (28.5%), Pseudomonas aeruginosa (17.4%), Staphylococcus aureus (11.8%), methicillin-resistant S. aureus (7.7%), anaerobic Gram-negative organisms (10.8%), and Enterococcus spp. (7%). Vancomycin was the most effective treatment for Gram-positive bacteria, and imipenem, piperacillin-tazobactam and amikacin were the most effective treatments for the Gram-negative bacteria. In conclusion, DFI is common among diabetic patients in Kuwait, and most of the cases evaluated in this study displayed polymicrobial etiology. The majority of isolates were multi-drug resistant. The data gathered in this study will be beneficial for future determinations of empirical therapy policies for the management of DFIs.
Similar articles
Raja NS.J Microbiol Immunol Infect. 2007 Feb;40(1):39-44.PMID: 17332905
Clinical and bacteriological profile of diabetic foot infections in a tertiary care.
Goh TC, Bajuri MY, C Nadarajah S, Abdul Rashid AH, Baharuddin S, Zamri KS.J Foot Ankle Res. 2020 Jun 16;13(1):36. doi: 10.1186/s13047-020-00406-y.PMID: 32546270 Free PMC article.
Li X, Qi X, Yuan G, Ju S, Yu Z, Deng W, Liu Y, Li Y, Bu X, Ding M, Li Q, Guo X.J Med Microbiol. 2018 Feb;67(2):160-168. doi: 10.1099/jmm.0.000658. Epub 2018 Jan 2.PMID: 29293083
Du F, Ma J, Gong H, Bista R, Zha P, Ren Y, Gao Y, Chen D, Ran X, Wang C.Front Endocrinol (Lausanne). 2022 May 19;13:881659. doi: 10.3389/fendo.2022.881659. eCollection 2022.PMID: 35663325 Free PMC article. Review.
In vitro activity of ertapenem: review of recent studies.
Wexler HM.J Antimicrob Chemother. 2004 Jun;53 Suppl 2:ii11-21. doi: 10.1093/jac/dkh204.PMID: 15150179 Review.
Cited by
Cited by
Multi-Instrumental Analysis Toward Exploring the Diabetic Foot Infection Microbiota.
Złoch M, Maślak E, Kupczyk W, Pomastowski P.Curr Microbiol. 2023 Jul 5;80(8):271. doi: 10.1007/s00284-023-03384-z.PMID: 37405539 Free PMC article.
Mohamed WF, Askora AA, Mahdy MMH, El-Hussieny EA, Abu-Shady HM.Arch Razi Inst. 2022 Dec 31;77(6):2187-2200. doi: 10.22092/ARI.2022.359032.2357. eCollection 2022 Dec.PMID: 37274914 Free PMC article.
Liu W, Song L, Sun W, Fang W, Wang C.Front Endocrinol (Lausanne). 2023 Jan 24;14:1113622. doi: 10.3389/fendo.2023.1113622. eCollection 2023.PMID: 36761201 Free PMC article.
The importance of inflammation control for the treatment of chronic diabetic wounds.
Worsley AL, Lui DH, Ntow-Boahene W, Song W, Good L, Tsui J.Int Wound J. 2023 Aug;20(6):2346-2359. doi: 10.1111/iwj.14048. Epub 2022 Dec 23.PMID: 36564054 Free PMC article. Review.
Li T, Li Z, Huang L, Tang J, Ding Z, Zeng Z, Liu Y, Liu J.Diabetes Metab Syndr Obes. 2022 Oct 26;15:3271-3283. doi: 10.2147/DMSO.S383701. eCollection 2022.PMID: 36311916 Free PMC article.